FRA:R9Z (China)
Â
Ordinary Shares - Class H
€
0.69
(-3.52%)
Dec 10
Business Description
ImmuneOnco Biopharmaceuticals (Shanghai) Inc
ISIN : CNE100006624
Share Class Description:
FRA:R9Z: Ordinary Shares - Class HDescription
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.25 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.27 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 9.12 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | -14.92 | |||||
| Future 3-5Y Total Revenue Growth Rate | 28.66 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.83 | |||||
| 9-Day RSI | 39.02 | |||||
| 14-Day RSI | 42.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.86 | |||||
| Quick Ratio | 4.86 | |||||
| Cash Ratio | 4.28 | |||||
| Days Sales Outstanding | 28.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -94519.43 | |||||
| Net Margin % | -98351.9 | |||||
| FCF Margin % | -95222 | |||||
| ROE % | -57.23 | |||||
| ROA % | -48.71 | |||||
| ROIC % | -137.02 | |||||
| ROC (Joel Greenblatt) % | -282.63 | |||||
| ROCE % | -55.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6160 | |||||
| PB Ratio | 3.57 | |||||
| Price-to-Tangible-Book | 3.43 | |||||
| EV-to-EBIT | -4.61 | |||||
| EV-to-EBITDA | -4.89 | |||||
| EV-to-Revenue | 4509.84 | |||||
| EV-to-FCF | -4.95 | |||||
| Price-to-Net-Current-Asset-Value | 4.89 | |||||
| Price-to-Net-Cash | 5.71 | |||||
| Earnings Yield (Greenblatt) % | -21.7 | |||||
| FCF Yield % | -16.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.05 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 42.16 | ||
| 14-Day ATR (€) | 0.046008 | ||
| 20-Day SMA (€) | 0.79675 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.53 - 1.2 | ||
| Shares Outstanding (Mil) | 407.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Frequently Asked Questions
What is ImmuneOnco Biopharmaceuticals (Shanghai) Inc(FRA:R9Z)'s stock price today?
The current price of FRA:R9Z is €0.69. The 52 week high of FRA:R9Z is €1.20 and 52 week low is €0.53.
When is next earnings date of ImmuneOnco Biopharmaceuticals (Shanghai) Inc(FRA:R9Z)?
The next earnings date of ImmuneOnco Biopharmaceuticals (Shanghai) Inc(FRA:R9Z) is .
Does ImmuneOnco Biopharmaceuticals (Shanghai) Inc(FRA:R9Z) pay dividends? If so, how much?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc(FRA:R9Z) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers